• OPEN AN ACCOUNT
Indian Indices
Sensex
82,276.07 50.15
( 0.06%)
Global Indices
Nasdaq
49,202.49 377.42
(0.77%)
Dow Jones
6,910.52 51.77
(0.75%)
Hang Seng
58,650.11 1,329.02
(2.32%)
Nikkei 225
10,802.86 122.27
(1.14%)
Forex
USD-INR
90.87 0.15
(0.16%)
EUR-INR
107.26 0.37
(0.35%)
GBP-INR
122.73 0.47
(0.39%)
JPY-INR
0.59 0.00
(0.51%)

EQUITY - MARKET SCREENER

Mangalam Worldwide Ltd
Industry :  Steel - Medium / Small
BSE Code
ISIN Demat
Book Value()
76659
INE0JYY01011
90.5538958
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MWL
19.46
803.25
EPS(TTM)
Face Value()
Div & Yield %
13.9
10
0.07
 

USFDA completes audit of Unit III of Eugia Pharma Specialities
Feb 07,2026
Aurobindo Pharma announced that the United States Food and Drug Administration (US FDA) inspected Unit-III, a Formulation manufacturing facility, of Eugia Pharma Specialities, a wholly owned subsidiary of the Company, situated at Phase-III, TSIIC, EPIP, IDA, Pashamylaram, Patancheru Revenue Mandal, Sangareddy District, 502307, Telangana, from 27 January to 06 February 2026.

The inspection concluded with 11 observations. The observations are procedural in nature and will be responded to within the stipulated time.